Precision therapies are on the horizon, but are they precise enough?
Can Something so Subjective be Turned into Data?
Engaging Patients in Therapeutic Development
Nudging Stakeholder Interests a Little Closer Together
Strategies to Get Back What’s Lost
43 Experts Weigh in on the Most Promising Disease-Modifying Therapies in PD
What the PD World is Working on
on Elephants, Intelligence, Neuromelanin, Regrowing Neurons and more
on The Divide Between Academia and Industry, Speeding Up Therapeutic Development, and more
Connecting the Dots in Parkinson’s Research